DelveInsight's Underactive Bladder Syndrome Market Insights report includes a comprehensive understanding of current ...

ImmunityBio stock rose 19.8% after FDA meeting on ANKTIVA bladder cancer treatment. Company to submit additional data within ...

After Hall of Fame athlete Deion Sanders’ announcement that he battled bladder cancer, doctors are sharing warning signs to monitor. Sanders, who is currently head football coach at the University of ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

(Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

This week, University of Colorado football coach Deion Sanders shared he was treated for aggressive bladder cancer. Surgeons removed the diseased bladder, and in a procedure called "neobladder ...

People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

Adenocarcinoma of the bladder is rare, originating from glandular cells, and can be primary or secondary, requiring accurate diagnosis for appropriate treatment. Diagnosis involves cystoscopy, biopsy, ...

Menopause often brings bladder health issues, including incontinence and urinary urgency, due to decreased estrogen levels.

Increases in variant histology bladder cancer in the US highlight the importance of precision in pathologic review of biopsy specimens. The diagnosis of variant histology bladder cancers is increasing ...

Urology departments in England and Wales have seen an increase in bladder inflammation among 16 to 24-year-olds ...